Baseline and stimulated serum inhibin levels as biomarkers of cisplatin-induced ovarian damage in female rats

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 1, 2008, Pages 82.e1-82.e6

  Yeh, John ^a   Kim, Beom Su ^a   Liang, Yuan Jing ^a   Peresie, Jennifer ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

chemotherapy; cisplatin; inhibin; ovarian damage; rats

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; GONADOTROPIN; INHIBIN A; INHIBIN B; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GONADOTROPIN BLOOD LEVEL; IMMUNOFLUORESCENCE; NICK END LABELING; NONHUMAN; OVARY DISEASE; OVARY FOLLICLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RAT; WESTERN BLOTTING;

EID: 37349082456     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.06.001     Document Type: Article

References (24)

1. Lee S.J., Schover L.R., Partridge A.H., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24 (2006) 2917-2931
2. Singh K.L., Davies M., and Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update 11 (2005) 69-89
3. Petraglia F., Zanin E., Faletti A., and Reis F.M. Inhibins: paracrine and endocrine effects in female reproductive function. Curr Opin Obstet Gynecol 11 (1999) 241-247
4. Hurwitz J.M., and Santoro N. Inhibins, activins, and follistatin in the aging female and male. Semin Reprod Med 22 (2004) 209-217
5. Penarrubia J., Fabregues F., Manau D., et al. Initial analysis of variability among basal hormone biomarkers of ovarian reserve. Reprod Biomed Online 8 (2004) 191-195
6. Jih M.H., Lu J.K., Wan Y.J., and Wu T.C. Inhibin subunit gene expression and distribution in the ovaries of immature, young adult, middle-aged, and old female rats. Endocrinology 132 (1993) 319-326
7. Kenny H.A., and Woodruff T.K. Follicle size class contributes to distinct secretion patterns of inhibin isoforms during the rat estrous cycle. Endocrinology 147 (2006) 51-60
8. Yeh J., and Kim B.S. Increasing blunting of inhibin responses to dynamic ovarian challenge is associated with reproductive aging in the rat. Reprod Sci 14 (2007) 10-19
9. Maneschi F., Benedetti-Panici P., Scambia G., Salerno M.G., D'Agostino G., and Mancuso S. Menstrual and hormone patterns in women treated with high-dose cisplatin and bleomycin. Gynecol Oncol 54 (1994) 345-348
10. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 169 (2000) 123-131
11. Wallace W.H., Shalet S.M., Crowne E.C., Morris-Jones P.H., Gattamaneni H.R., and Price D.A. Gonadal dysfunction due to cis-platinum. Med Pediatr Oncol 17 (1989) 409-413
12. Palumbo A., and Yeh J. In situ localization of apoptosis in the rat ovary during follicular atresia. Biol Reprod 51 (1994) 888-895
13. Yeh J., Kim B., Liang Y.J., and Peresie J. Müllerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage. Biochem Biophys Res Commun 348 (2006) 337-344
14. Bicsak T.A., Cajander S.B., Vale W., and Hsueh A.J. Inhibin: studies of stored and secreted forms by biosynthetic labeling and immunodetection in cultured rat granulosa cells. Endocrinology 122 (1988) 741-748
15. Bilezikjian L.M., Vaughan J.M., and Vale W.W. Characterization and the regulation of inhibin/activin subunit proteins of cultured rat anterior pituitary cells. Endocrinology 133 (1993) 2545-2553
16. Meunier H., Cajander S.B., Roberts V.J., et al. Rapid changes in the expression of inhibin alpha-, beta A-, and beta B-subunits in ovarian cell types during the rat estrous cycle. Mol Endocrinol 2 (1988) 1352-1363
17. Liao Y., Abel U., Grobholz R., et al. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade. Hum Pathol 36 (2005) 1186
18. Bath L.E., Wallace W.H., Shaw M.P., Fitzpatrick C., and Anderson R.A. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-müllerian hormone, inhibin B, and ovarian ultrasound. Hum Reprod 18 (2003) 2368-2374
19. Boersma A.W.M., Nooter K., Oostrum R.G., and Stoter G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin. Cytometry 24 (1996) 123-130
20. Schmitt E., Paquet C., Beauchemin M., and Bertrand R. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation. Oncogene Res 23 (2004) 3915-3931
21. Borovskaya T.G., Goldberg V.E., Fomina T.I., et al. Morphological and functional state of rat ovaries in early and late periods after administration of platinum cytostatics. Bull Exp Biol Med 137 (2004) 331-335
22. Yucebilgin M.S., Terek M.C., Ozsaran A., et al. Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility. Aust N Z J Obstet Gynaecol 44 (2004) 6-9
23. Kevenaar M.E., Meerasahib M.F., Kramer P., et al. Serum anti-müllerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 147 (2006) 3228-3234
24. Jarrell J., Mattison D.R., McMahon A., and Younglai E.V. An evaluation of the serum FSH as a biomarker for ovarian toxicity in the rat. Reprod Toxicol 2 (1988) 111-115